Table 5. Distribution, intensity, overall score of TAK-1 and T factor subgroups on patients with SCC.
| TAK-1 | ||||||||||||||||||
| Distribution | Intensity | Overall score | ||||||||||||||||
| χ2= 9.264 | χ2=24.815 | χ2=22.099 | ||||||||||||||||
| Significance | Cramer’s V=0.388 p= 0.099, p= 0.099 |
Cramer’s V=0.643 p<0.001, p<0.001 |
Cramer’s V=0.609 p<0.001, p<0.001 |
|||||||||||||||
| T factor | 11-25% | 26-50% | >51% | Slight yellow | Dark yellow | Brown | No staining (0-2) | Mild (3-4) | Severe (5-6) | |||||||||
| n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
| 1A (n=2) | 2 | 100,0 | 0 | 0,0 | 0 | 0,0 | 2 | 100,0 | 0 | 0,0 | 0 | 0,0 | 2 | 100,0 | 0 | 0,0 | 0 | 0,0 |
| 1B (n=8) | 6 | 75,0 | 2 | 25,0 | 0 | 0,0 | 3 | 37,5 | 5 | 62,5 | 0 | 0,0 | 3 | 37,5 | 5 | 62,5 | 0 | 0,0 |
| 2A (n=16) | 3 | 18,8 | 9 | 56,3 | 4 | 25,0 | 1 | 6,3 | 1 | 6,3 | 14 | 87,4 | 1 | 6,3 | 2 | 12,4 | 13 | 81,3 |
| 2B (n=9) | 4 | 18,8 | 4 | 56,3 | 1 | 25,0 | 0 | 0,0 | 2 | 22,2 | 7 | 77,8 | 0 | |||||
| TAK-1: Transforming growth factor (TGF)-β-activated kinase 1; SCC: Squamous cell carcinoma. | ||||||||||||||||||